Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review
Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.
Edwards Lifesciences Corp Key Recent Developments
Jan 27,2021: Edwards Lifesciences reports fourth quarter results for quarter ended December 31, 2020
Oct 21,2020: Edwards Lifesciences reports third quarter results
Jul 23,2020: Edwards Lifesciences reports second quarter results 2020
Jul 16,2020: Mentice receives order of total SEK 7.0 million from Edwards Lifesciences
Jul 15,2020: Paul LaViolette appointed to Edwards Lifesciences board of directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.
Edwards Lifesciences Corp Key Recent Developments
Jan 27,2021: Edwards Lifesciences reports fourth quarter results for quarter ended December 31, 2020
Oct 21,2020: Edwards Lifesciences reports third quarter results
Jul 23,2020: Edwards Lifesciences reports second quarter results 2020
Jul 16,2020: Mentice receives order of total SEK 7.0 million from Edwards Lifesciences
Jul 15,2020: Paul LaViolette appointed to Edwards Lifesciences board of directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Edwards Lifesciences Corp - Key Facts
Edwards Lifesciences Corp - Key Employees
Edwards Lifesciences Corp - Key Employee Biographies
Edwards Lifesciences Corp - Major Products and Services
Edwards Lifesciences Corp - History
Edwards Lifesciences Corp - Company Statement
Edwards Lifesciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Edwards Lifesciences Corp - Business Description
Product Category: Critical Care
Overview
Performance
Product Category: Surgical Structural Heart
Overview
Performance
Product Category: Transcatheter Aortic Valve Replacement
Overview
Performance
Product Category: Transcatheter Mitral and Tricuspid Therapies
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Edwards Lifesciences Corp - Corporate Strategy
Edwards Lifesciences Corp - SWOT Analysis
SWOT Analysis - Overview
Edwards Lifesciences Corp - Strengths
Edwards Lifesciences Corp - Weaknesses
Edwards Lifesciences Corp - Opportunities
Edwards Lifesciences Corp - Threats
Edwards Lifesciences Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Edwards Lifesciences Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 27, 2021: Edwards Lifesciences reports fourth quarter results for quarter ended December 31, 2020
Oct 21, 2020: Edwards Lifesciences reports third quarter results
Jul 23, 2020: Edwards Lifesciences reports second quarter results 2020
Jul 16, 2020: Mentice receives order of total SEK 7.0 million from Edwards Lifesciences
Jul 15, 2020: Paul LaViolette appointed to Edwards Lifesciences board of directors
Jul 15, 2020: Medial EarlySign and Centric Consulting join forces to increase hospital adoption of clinical AI solutions
Jul 14, 2020: Edwards Lifesciences and Abbott to settle transcatheter litigation
Jul 13, 2020: Abbott agrees to global Transcatheter Litigation Settlement with Edwards Lifesciences
May 04, 2020: UPS supports Edwards Lifesciences’ Distribution Of Critical ICU monitoring equipment and other medical technologies
Apr 23, 2020: Edwards Lifesciences reports financial results for the quarter ended March 31, 2020
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Edwards Lifesciences Corp - Key Facts
Edwards Lifesciences Corp - Key Employees
Edwards Lifesciences Corp - Key Employee Biographies
Edwards Lifesciences Corp - Major Products and Services
Edwards Lifesciences Corp - History
Edwards Lifesciences Corp - Company Statement
Edwards Lifesciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Edwards Lifesciences Corp - Business Description
Product Category: Critical Care
Overview
Performance
Product Category: Surgical Structural Heart
Overview
Performance
Product Category: Transcatheter Aortic Valve Replacement
Overview
Performance
Product Category: Transcatheter Mitral and Tricuspid Therapies
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Edwards Lifesciences Corp - Corporate Strategy
Edwards Lifesciences Corp - SWOT Analysis
SWOT Analysis - Overview
Edwards Lifesciences Corp - Strengths
Edwards Lifesciences Corp - Weaknesses
Edwards Lifesciences Corp - Opportunities
Edwards Lifesciences Corp - Threats
Edwards Lifesciences Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Edwards Lifesciences Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 27, 2021: Edwards Lifesciences reports fourth quarter results for quarter ended December 31, 2020
Oct 21, 2020: Edwards Lifesciences reports third quarter results
Jul 23, 2020: Edwards Lifesciences reports second quarter results 2020
Jul 16, 2020: Mentice receives order of total SEK 7.0 million from Edwards Lifesciences
Jul 15, 2020: Paul LaViolette appointed to Edwards Lifesciences board of directors
Jul 15, 2020: Medial EarlySign and Centric Consulting join forces to increase hospital adoption of clinical AI solutions
Jul 14, 2020: Edwards Lifesciences and Abbott to settle transcatheter litigation
Jul 13, 2020: Abbott agrees to global Transcatheter Litigation Settlement with Edwards Lifesciences
May 04, 2020: UPS supports Edwards Lifesciences’ Distribution Of Critical ICU monitoring equipment and other medical technologies
Apr 23, 2020: Edwards Lifesciences reports financial results for the quarter ended March 31, 2020
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Edwards Lifesciences Corp, Key Facts
Edwards Lifesciences Corp, Key Employees
Edwards Lifesciences Corp, Key Employee Biographies
Edwards Lifesciences Corp, Major Products and Services
Edwards Lifesciences Corp, History
Edwards Lifesciences Corp, Other Locations
Edwards Lifesciences Corp, Subsidiaries
Edwards Lifesciences Corp, Key Competitors
Edwards Lifesciences Corp, Ratios based on current share price
Edwards Lifesciences Corp, Annual Ratios
Edwards Lifesciences Corp, Annual Ratios (Cont...1)
Edwards Lifesciences Corp, Annual Ratios (Cont...2)
Edwards Lifesciences Corp, Interim Ratios
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Edwards Lifesciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Edwards Lifesciences Corp, Key Facts
Edwards Lifesciences Corp, Key Employees
Edwards Lifesciences Corp, Key Employee Biographies
Edwards Lifesciences Corp, Major Products and Services
Edwards Lifesciences Corp, History
Edwards Lifesciences Corp, Other Locations
Edwards Lifesciences Corp, Subsidiaries
Edwards Lifesciences Corp, Key Competitors
Edwards Lifesciences Corp, Ratios based on current share price
Edwards Lifesciences Corp, Annual Ratios
Edwards Lifesciences Corp, Annual Ratios (Cont...1)
Edwards Lifesciences Corp, Annual Ratios (Cont...2)
Edwards Lifesciences Corp, Interim Ratios
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Edwards Lifesciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Edwards Lifesciences Corp, Performance Chart (2016 - 2020)
Edwards Lifesciences Corp, Ratio Charts
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021
Edwards Lifesciences Corp, Performance Chart (2016 - 2020)
Edwards Lifesciences Corp, Ratio Charts
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Edwards Lifesciences Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021